Products

Signal Tracker Data Platform Data Enrichment API Intelligence desk

Solutions

Deal Origination Executive Search For Sales Teams Corporate Development For Founders For Agencies For Investors Signal-Based Outbound Competitive Intelligence Funding Signals Competitor Monitoring

Explore

Companies Live Signals Markets Trends

Resources

Signal Checker Blog Integrations FAQ Contact Pricing
Login Start Free
LIB Therapeutics logo — Where lower is better!

LIB Therapeutics

Where lower is better!

Founded 2015 United States Cincinnati, United States 10 employees Pharmaceutical

General Information

Company Name LIB Therapeutics
Founded Year 2015
Location United States Cincinnati, United States +1
Employees 10
Industries Pharmaceutical
Social

Get notified when LIB Therapeutics moves

Funding, new markets, leadership changes, hiring surges — one e-mail, only when something happens.

Free · no account needed

About LIB Therapeutics

LIB Therapeutics is a late-stage biopharmaceutical company established in 2015. The company's mission is to provide novel, safe, and convenient subcutaneous and oral PCSK9 inhibitors to millions of patients at very high and high-risk of cardiovascular disease (CVD) and the 30 million individuals with familial hypercholesterolemia (FH) who require significant reductions in low-density lipoprotein-cholesterol (LDL-C) despite maximally tolerated statins and other lipid-lowering agents. Based in the United States, LIB Therapeutics is dedicated to addressing significant unmet medical needs in the field of cardiovascular health. With the slogan "Where lower is better!", LIB Therapeutics aims to disrupt the pharmaceutical industry by focusing on innovative approaches to combat CVD and FH. Although specific details about the last investment and investors are not available, the company's commitment to developing solutions for these critical health issues positions it as a compelling prospect for potential investors. As the demand for effective treatments in the cardiovascular space continues to grow, LIB Therapeutics' dedication to delivering pioneering therapies presents an enticing opportunity for venture capitalists seeking to make a meaningful impact in the pharmaceutical sector.

Taxonomy: biopharmaceutical, PCSK9 inhibitors, cardiovascular disease, familial hypercholesterolemia, LDL-C, lipid lowering agents, late-stage company, subcutaneous medication, oral medication, therapeutics, cholesterol management, high-risk patients, statins, drug development, clinical trials

No funding data available for LIB Therapeutics yet.

Get notified when LIB Therapeutics raises funding

LIB Therapeutics Alternatives & Competitors

LIB Therapeutics vs
National Custom Compounding (Pharmacy)
National Custom Compounding (Pharmacy) Australia

Caring, Innovative, Personally Made Compounding Medicines

11 employees
Pharmaceutical, Retail
LIB Therapeutics vs
Chawla Medicos
Chawla Medicos India

Pharmaceutical Drugs Manufacturers, Suppliers, Exporters,Dealers in India and worldwide.

14 employees
Health Care, Pharmaceutical
LIB Therapeutics vs
ChatGPT
ChatGPT India

A promise to keep you well.

Select
55 employees
Health Care, Manufacturing

FAQ About LIB Therapeutics

Where lower is better!
LIB Therapeutics was founded in 2015.
LIB Therapeutics is headquartered in Cincinnati, United States.
LIB Therapeutics operates in the following industries: Pharmaceutical.
LIB Therapeutics has approximately 10 employees.
Top alternatives and competitors to LIB Therapeutics include National Custom Compounding (Pharmacy), Chawla Medicos, ChatGPT, Vitec Appva AB, SHARx, LLC. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
LIB Therapeutics and National Custom Compounding (Pharmacy) are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Don't just browse. Track.

Signal Tracker monitors LIB Therapeutics and millions of companies for funding rounds, hiring surges, product changes, and 40+ signal types — so you never miss an opportunity.

Start Tracking — Free

One analytics cookie (Google Analytics). Cookie Policy